HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Achim Aigner Selected Research

poly(ethylenimine sulfide)

2/2022Unmodified and tyrosine-modified polyethylenimines as potential carriers for siRNA: Biophysical characterization and toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Achim Aigner Research Topics

Disease

71Neoplasms (Cancer)
04/2022 - 04/2002
18Carcinoma (Carcinomatosis)
12/2021 - 08/2002
13Glioblastoma (Glioblastoma Multiforme)
01/2022 - 04/2002
7Glioma (Gliomas)
01/2021 - 12/2003
5Carcinogenesis
02/2021 - 12/2003
5Neoplasm Metastasis (Metastasis)
11/2020 - 03/2010
4Melanoma (Melanoma, Malignant)
11/2020 - 06/2013
4Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2013
3Brain Neoplasms (Brain Tumor)
01/2022 - 04/2002
3Adenocarcinoma
06/2021 - 01/2008
2Lung Neoplasms (Lung Cancer)
12/2021 - 01/2008
2Parkinson Disease (Parkinson's Disease)
08/2020 - 12/2017
2Prostatic Neoplasms (Prostate Cancer)
04/2020 - 08/2002
2Breast Neoplasms (Breast Cancer)
01/2018 - 02/2005
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2013 - 03/2010
2Ovarian Neoplasms (Ovarian Cancer)
01/2013 - 07/2008
1Hemolysis
02/2022
1Inflammation (Inflammations)
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Fibrosis (Cirrhosis)
01/2022
1COVID-19
01/2022
1Myocarditis (Carditis)
01/2022
1Burkitt Lymphoma (Burkitt's Lymphoma)
12/2021
1T-Cell Leukemia (Leukemia, T Cell)
12/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2021
1Stomach Neoplasms (Stomach Cancer)
12/2020
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
08/2020
1Hyperplasia
04/2020

Drug/Important Bio-Agent (IBA)

32Small Interfering RNA (siRNA)IBA
01/2022 - 01/2006
14Proteins (Proteins, Gene)FDA Link
12/2020 - 08/2002
12Pharmaceutical PreparationsIBA
01/2022 - 08/2004
10MicroRNAs (MicroRNA)IBA
01/2022 - 05/2011
9PolyethyleneimineIBA
02/2020 - 07/2006
8SurvivinIBA
01/2022 - 10/2011
7Carrier Proteins (Binding Protein)IBA
01/2018 - 08/2002
6pleiotrophin (HARP)IBA
12/2011 - 04/2002
5Biological ProductsIBA
07/2019 - 12/2005
5Messenger RNA (mRNA)IBA
02/2013 - 04/2002
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2011 - 04/2002
5Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
11/2011 - 12/2003
4Transcription Factors (Transcription Factor)IBA
10/2021 - 06/2013
4Cytostatic AgentsIBA
05/2020 - 05/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2013 - 05/2006
4Catalytic RNA (Ribozymes)IBA
01/2006 - 04/2002
3AntigensIBA
04/2022 - 10/2016
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2022 - 07/2015
3CytokinesIBA
01/2022 - 03/2010
3RNA (Ribonucleic Acid)IBA
09/2020 - 07/2008
3AntibodiesIBA
05/2020 - 04/2014
3Phosphotransferases (Kinase)IBA
02/2020 - 04/2002
3PolymersIBA
12/2013 - 11/2011
3DNA (Deoxyribonucleic Acid)IBA
12/2013 - 12/2009
3Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA
08/2013 - 08/2011
2LipidsIBA
01/2022 - 04/2014
2Proteoglycans (Proteoglycan)IBA
12/2021 - 11/2011
2Nucleic AcidsIBA
12/2021 - 05/2021
2ChromatinIBA
02/2021 - 12/2020
2Histone Deacetylase InhibitorsIBA
02/2021 - 07/2019
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021 - 11/2013
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2020 - 04/2002
2Cisplatin (Platino)FDA LinkGeneric
05/2020 - 04/2014
2Trastuzumab (Herceptin)FDA Link
05/2020 - 02/2005
2Caspase 3 (Caspase-3)IBA
02/2020 - 01/2016
2Adenosine Triphosphate (ATP)IBA
01/2020 - 01/2016
2Therapeutic UsesIBA
10/2019 - 11/2011
2LectinsIBA
01/2019 - 08/2004
2CarcinogensIBA
09/2018 - 09/2004
2Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 05/2011
2LigandsIBA
01/2017 - 12/2003
2Keratins (Keratin)IBA
01/2016 - 04/2014
2Docetaxel (Taxotere)FDA Link
04/2014 - 05/2011
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2011 - 08/2002
2Anaplastic Lymphoma KinaseIBA
02/2009 - 04/2002
2Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA
12/2005 - 12/2003
1Immunoglobulin FragmentsIBA
04/2022
1poly(ethylenimine sulfide)IBA
02/2022
1Oncogene Proteins (Oncogene Protein)IBA
01/2022
1Carvedilol (Coreg)FDA LinkGeneric
01/2022
1VaccinesIBA
01/2022
1ProdrugsIBA
12/2021
1Tripartite Motif ProteinsIBA
12/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021
1Androgen Receptors (Androgen Receptor)IBA
12/2021
1OligonucleotidesIBA
12/2021
1myocardinIBA
10/2021
1TetraspaninsIBA
10/2021
1SelectinsIBA
06/2021
1Integrin alphaVIBA
06/2021
1poly(propyleneimine)IBA
05/2021
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
08/2020
1EscitalopramFDA Link
08/2020
1ParaffinIBA
05/2020
1Formaldehyde (Formol)FDA Link
05/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2020
1Long Noncoding RNAIBA
04/2020
1Biomarkers (Surrogate Marker)IBA
04/2020

Therapy/Procedure

28Therapeutics
01/2022 - 08/2002
7Drug Therapy (Chemotherapy)
07/2021 - 08/2004
3Radiotherapy
09/2020 - 01/2017
2RNAi Therapeutics
12/2011 - 10/2011